A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Inhibition Analysis and High-Resolution Crystal Structure of Mus musculus Glutathione Transferase P1-1
Tekijät: Kupreienko Oleksii, Pouliou Fotini, Konstandinidis Konstantinos, Axarli Irene, Douni Eleni, Papageorgiou Anastassios C., Labrou Nikolaos E.
Kustantaja: MDPI
Julkaisuvuosi: 2023
Journal: Biomolecules
Tietokannassa oleva lehden nimi: BIOMOLECULES
Lehden akronyymi: BIOMOLECULES
Artikkelin numero: 613
Vuosikerta: 13
Numero: 4
Sivujen määrä: 15
eISSN: 2218-273X
DOI: https://doi.org/10.3390/biom13040613
Verkko-osoite: https://doi.org/10.3390/biom13040613
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/179811672
Multidrug resistance is a significant barrier that makes anticancer therapies less effective. Glutathione transferases (GSTs) are involved in multidrug resistance mechanisms and play a significant part in the metabolism of alkylating anticancer drugs. The purpose of this study was to screen and select a lead compound with high inhibitory potency against the isoenzyme GSTP1-1 from Mus musculus (MmGSTP1-1). The lead compound was selected following the screening of a library of currently approved and registered pesticides that belong to different chemical classes. The results showed that the fungicide iprodione [3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide] exhibited the highest inhibition potency (ΙC50 = 11.3 ± 0.5 μΜ) towards MmGSTP1-1. Kinetics analysis revealed that iprodione functions as a mixed-type inhibitor towards glutathione (GSH) and non-competitive inhibitor towards 1-chloro-2,4-dinitrobenzene (CDNB). X-ray crystallography was used to determine the crystal structure of MmGSTP1-1 at 1.28 Å resolution as a complex with S-(p-nitrobenzyl)glutathione (Nb-GSH). The crystal structure was used to map the ligand-binding site of MmGSTP1-1 and to provide structural data of the interaction of the enzyme with iprodione using molecular docking. The results of this study shed light on the inhibition mechanism of MmGSTP1-1 and provide a new compound as a potential lead structure for future drug/inhibitor development.
Ladattava julkaisu This is an electronic reprint of the original article. |